Having trouble accessing articles? Reset your cache.

AI play Recursion raises $121M to expand into new drug discovery

Recursion’s $121 million series C round will allow the company to expand its artificial intelligence-based drug repurposing platform for rare diseases and develop capabilities for new drug discovery while pushing its pair of lead programs deeper into the

Read the full 384 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE